Tag Archives: British Journal of Clinical Pharmacology

More on the Association Between Anticholinergics and Dementia Risk (BBC News / JAMA Internal Medicine / Bazian / BJCP)

Summary Fresh research appears to confirm the association between the use of anticholinergic drugs (prescribed for the treatment of depression, epilepsy, Parkinson’s Disease and bladder problems) and an increased risk of developing Alzheimer’s Disease and related dementias (ADRD). Statistical research … Continue reading

Posted in BBC News, In the News, NHS Digital (Previously NHS Choices), UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Pharmacological Treatment of Agitation in Persons With Dementia (British Journal of Clinical Pharmacology)

Summary A systematic review and meta‐analysis of pharmaceutical treatments for alleviating agitation in dementia has been performed. Regarding the efficacy and treatment acceptability of these medications, it is reported that: “Risperidone, SSRIs as a class and Dextromethorphan / Quinidine demonstrated … Continue reading

Posted in Antipsychotics, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Mental Health, Pharmacological Treatments, Quick Insights, Systematic Reviews | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Reducing Under-Usage of Medications (British Journal of Clinical Pharmacology)

Summary A meta-analysis investigating the impact of pharmaceutical care interventions for medication underuse in older people has shown that such interventions, including medication reviews, can reduce medication under-use in older people. Full Text Link Reference Meid, AD. Lampert, A. [and] … Continue reading

Posted in Commissioning, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Standards, Systematic Reviews, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Reducing Antipsychotic Prescribing for BPSD (BMJ / JAMA / JAMA Psychiatry / BJCP)

Summary This BMJ “Change page” article discusses the potential harms associated with use of antipsychotics in people with dementia, and covers guidelines recommending restrictions in their use. Risperidone is the antipsychotic recommended for use in the treatment of aggression associated … Continue reading

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, Statistics, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment